Davide Dalu
Impact in
-
- COVID-19 and healthcare impacts
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 11
- COVID-19 and healthcare impacts 5
- Drug Transport and Resistance Mechanisms 2
- Viral-associated cancers and disorders 2
- Cancer Immunotherapy and Biomarkers 2
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Nicla La Verde (17 shared papers)Maria Silvia Cona (13 shared papers)Eliana Rulli (6 shared papers)Sheila Piva (4 shared papers)Rossana Berardi (4 shared papers)Lorenzo Ruggieri (9 shared papers)V. Filipazzi (5 shared papers)Anna Moretti (2 shared papers)
- Journals
- International Journal of Molecular Sciences (2 papers)Annals of Oncology (2 papers)International Journal of Cancer (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Davide Dalu
18 papers receiving 81 citations
Peers
Comparison fields: 5 of 41
- Oncology 29
- Infectious Diseases 10
- Aging 1
- Otorhinolaryngology 2
- Social Psychology 10
Countries citing papers authored by Davide Dalu
This map shows the geographic impact of Davide Dalu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Dalu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Dalu more than expected).
Fields of papers citing papers by Davide Dalu
This network shows the impact of papers produced by Davide Dalu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Dalu. The network helps show where Davide Dalu may publish in the future.
Co-authors
The 25 scholars most cited alongside Davide Dalu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 12 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 7 | |
| 5 | 2023 | 7 | |
| 6 | 2020 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2015 | 6 | |
| 9 | 2023 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2021 | 0 | |
| 20 | 2024 | 0 |
About Davide Dalu
Davide Dalu is a scholar working on Oncology, Infectious Diseases, Social Psychology, Genetics and Pathology and Forensic Medicine, having authored 22 papers that have together received 84 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (5 papers), BRCA gene mutations in cancer (3 papers), LGBTQ Health, Identity, and Policy (3 papers), COVID-19 Clinical Research Studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Viral-associated cancers and disorders (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Oncology (29 citations), Infectious Diseases (10 citations), Aging (1 citation), Otorhinolaryngology (2 citations) and Social Psychology (10 citations). Davide Dalu has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Nicla La Verde, Maria Silvia Cona, Eliana Rulli, Sheila Piva, Rossana Berardi, Lorenzo Ruggieri, V. Filipazzi, Anna Moretti, Luca Meroni and María Teresa Cattaneo. Their work appears in journals such as International Journal of Molecular Sciences, Annals of Oncology, International Journal of Cancer, Critical Reviews in Oncology/Hematology and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.